ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,277.51
0.80%
Dow Jones
38,686.32
1.51%
US Dollar vs MXN
16.99024
0.00%
Brent Oil
81.295
0.00%
Bitcoin
67,718.79
-0.01%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Zealand Pharma AS (ZEAL)

  7. Zealand Pharma AS (ZEAL) Noticias

ZEAL

Zealand Pharma AS (ZEAL)

Zealand Pharma AS
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ZEAL
FechaHoraFuenteTítuloSímboloCompañía
10/11/202208:00GlobeNewswire Inc.Zealand Pharma Announces Financial Results for the First Nine Months of 2022NASDAQ:ZEALZealand Pharma AS
08/11/202207:30GlobeNewswire Inc.Zealand Pharma to Participate in Upcoming Investor ConferencesNASDAQ:ZEALZealand Pharma AS
03/11/202203:00GlobeNewswire Inc.Zealand Pharma Hosts Conference Call on November 10 at 4pm CET (10am ET) to Present Third Quarter Results for 2022NASDAQ:ZEALZealand Pharma AS
01/11/202211:00GlobeNewswire Inc.Zealand Pharma Announces Presentations at The Obesity Society Annual MeetingNASDAQ:ZEALZealand Pharma AS
11/10/202210:05GlobeNewswire Inc.Zealand Pharma major shareholder announcement: Polar CapitalNASDAQ:ZEALZealand Pharma AS
10/10/202210:12GlobeNewswire Inc.Zealand Pharma major shareholder announcement: Van Herk InvestmentsNASDAQ:ZEALZealand Pharma AS
07/10/202201:41GlobeNewswire Inc.Zealand Pharma completes registration of capital increaseNASDAQ:ZEALZealand Pharma AS
04/10/202215:07GlobeNewswire Inc.Zealand Pharma announces completion of a directed issue and private placement of 4,975,000 new ordinary shares raising gross proceeds of approx. DKK 786 millionNASDAQ:ZEALZealand Pharma AS
04/10/202210:05GlobeNewswire Inc.Zealand Pharma announces directed issue and private placement of approximately 4.5m new sharesNASDAQ:ZEALZealand Pharma AS
30/09/202215:15TipRanksNeedham Sticks to Their Buy Rating for Zealand Pharma (ZEAL)NASDAQ:ZEALZealand Pharma AS
30/09/202215:00GlobeNewswire Inc.Total number of shares and voting rights in Zealand Pharma at September 30, 2022NASDAQ:ZEALZealand Pharma AS
30/09/202206:41TipRanksZealand Pharma’s (NASDAQ:ZEAL) Phase 3 SBS Trial Sees Positive ResultsNASDAQ:ZEALZealand Pharma AS
30/09/202205:15GlobeNewswire Inc.Zealand Pharma Announces Positive Results from Phase 3 Trial of Glepaglutide in Patients with Short Bowel Syndrome (EASE 1)NASDAQ:ZEALZealand Pharma AS
21/09/202207:15GlobeNewswire Inc.Zealand Pharma Announces Oral Presentation of Phase 2 Data for BI 456906 at the 58th Annual Meeting of the European Association for the Study of Diabetes (EASD)NASDAQ:ZEALZealand Pharma AS
19/09/202201:00GlobeNewswire Inc.Zealand Pharma Presents Data from Phase 3 Trial of Dasiglucagon in Congenital Hyperinsulinism at the 60th Annual ESPE MeetingNASDAQ:ZEALZealand Pharma AS
14/09/202205:11TipRanksAnalysts’ Top Healthcare Picks: Zealand Pharma (ZEAL), POINT Biopharma Global (PNT)NASDAQ:ZEALZealand Pharma AS
13/09/202215:05GlobeNewswire Inc.Zealand Pharma grants warrants to employees in DenmarkNASDAQ:ZEALZealand Pharma AS
08/09/202215:05GlobeNewswire Inc.Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee WarrantsNASDAQ:ZEALZealand Pharma AS
07/09/202210:00GlobeNewswire Inc.Zealand Pharma to Participate in Morgan Stanley 20th Annual Global Healthcare ConferenceNASDAQ:ZEALZealand Pharma AS
07/09/202201:00GlobeNewswire Inc.Zealand Pharma Announces Global License and Development Agreement with Novo Nordisk for ZEGALOGUE® (dasiglucagon)NASDAQ:ZEALZealand Pharma AS
31/08/202214:30GlobeNewswire Inc.Total number of shares and voting rights in Zealand Pharma at August 31, 2022NASDAQ:ZEALZealand Pharma AS
24/08/202203:30GlobeNewswire Inc.Zealand Pharma Appoints Henriette Wennicke as Chief Financial OfficerNASDAQ:ZEALZealand Pharma AS
11/08/202212:30TipRanksAnalysts Are Bullish on Top Healthcare Stocks: Trevena (TRVN), Zealand Pharma (ZEAL)NASDAQ:ZEALZealand Pharma AS
11/08/202208:00GlobeNewswire Inc.Zealand Pharma Announces Financial Results for the First Half of 2022NASDAQ:ZEALZealand Pharma AS
08/08/202215:30GlobeNewswire Inc.Updated notice to holders of ADSs regarding termination of Deposit AgreementNASDAQ:ZEALZealand Pharma AS
08/08/202215:05GlobeNewswire Inc.Zealand Pharma Announces Voluntary Delisting of American Depositary Shares from the U.S.-Based Nasdaq Global Select MarketNASDAQ:ZEALZealand Pharma AS
04/08/202208:00GlobeNewswire Inc.Zealand Pharma Hosts Conference Call on August 11 at 4 pm CET (10am ET) to Present Second Quarter Results for 2022NASDAQ:ZEALZealand Pharma AS
14/07/202205:45TipRanksZealand Pharma (ZEAL) Receives a Buy from NeedhamNASDAQ:ZEALZealand Pharma AS
30/06/202208:44GlobeNewswire Inc.Total number of shares and voting rights in Zealand Pharma at June 30, 2022NASDAQ:ZEALZealand Pharma AS
15/06/202215:00GlobeNewswire Inc.Transactions in Zealand Pharma A/S securities by persons discharging managerial responsibilitiesNASDAQ:ZEALZealand Pharma AS
 Showing the most relevant articles for your search:NASDAQ:ZEAL

Su Consulta Reciente

FX
EURUSD
Euro vs US Dollar
AMEX
XLV
Health Care Select Sector
SPI
SP500
S&P 500
NYSE
VZ
Verizon Communications
NASDAQ
TSLA
Tesla
CCOM
OILBRENT
Brent Oil
NYSE
MCD
McDonalds
USOTC
BASFY
BASF (QX)
NYSE
NKE
Nike
NYSE
CVX
Chevron
NASDAQ
AAPL
Apple
AMEX
SPY
SPDR S&P 500
NASDAQ
GOOGL
Alphabet
COIN
SOLUSD
Solana
NYSE
MRK
Merck
NASDAQ
MSFT
Microsoft
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados